J Gibassier

401 total citations
25 papers, 224 citations indexed

About

J Gibassier is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, J Gibassier has authored 25 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in J Gibassier's work include Thyroid Disorders and Treatments (6 papers), Glutathione Transferases and Polymorphisms (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). J Gibassier is often cited by papers focused on Thyroid Disorders and Treatments (6 papers), Glutathione Transferases and Polymorphisms (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). J Gibassier collaborates with scholars based in France, Canada and United States. J Gibassier's co-authors include Catherine Massart, N Génetet, D Maugendre, Arnaud Agin, Romain Barbet, C. Massart, Michèle d’Herbomez, Rémy Sapin, E. Sonnet and Patricia Fergelot and has published in prestigious journals such as Clinical Chemistry, Clinica Chimica Acta and Thyroid.

In The Last Decade

J Gibassier

25 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Gibassier France 10 107 65 51 51 32 25 224
Mosin Saleem Khan India 13 103 1.0× 205 3.2× 69 1.4× 92 1.8× 55 1.7× 39 417
Caroline S. Kim United States 8 143 1.3× 142 2.2× 17 0.3× 53 1.0× 44 1.4× 11 313
Maria Teresa Ionta Italy 11 28 0.3× 77 1.2× 24 0.5× 107 2.1× 24 0.8× 24 230
Bojana Janković Canada 5 172 1.6× 48 0.7× 27 0.5× 26 0.5× 24 0.8× 6 317
Esther Ravinsky Canada 8 82 0.8× 39 0.6× 82 1.6× 71 1.4× 14 0.4× 23 300
Ninni Mu Sweden 9 117 1.1× 96 1.5× 21 0.4× 45 0.9× 44 1.4× 13 254
G Feifel Germany 8 120 1.1× 61 0.9× 39 0.8× 75 1.5× 103 3.2× 25 360
Constantinos Troungos Greece 10 17 0.2× 116 1.8× 41 0.8× 75 1.5× 23 0.7× 18 234
Daria Domańska Poland 13 46 0.4× 135 2.1× 35 0.7× 68 1.3× 88 2.8× 18 328
Marc‐Olivier Turgeon Canada 6 127 1.2× 172 2.6× 9 0.2× 33 0.6× 38 1.2× 8 305

Countries citing papers authored by J Gibassier

Since Specialization
Citations

This map shows the geographic impact of J Gibassier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Gibassier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Gibassier more than expected).

Fields of papers citing papers by J Gibassier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Gibassier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Gibassier. The network helps show where J Gibassier may publish in the future.

Co-authorship network of co-authors of J Gibassier

This figure shows the co-authorship network connecting the top 25 collaborators of J Gibassier. A scholar is included among the top collaborators of J Gibassier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Gibassier. J Gibassier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massart, C., R Sapin, J Gibassier, Arnaud Agin, & M. D’Herbomez. (2009). Nouveaux dosages des anticorps anti-récepteur de la TSH : performances analytiques et cliniques dans le diagnostic de la maladie de Basedow. Annales de biologie clinique. 67(6). 661–667. 2 indexed citations
2.
Massart, Catherine, J Gibassier, & M. D’Herbomez. (2009). Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: Comparison with the second generation human TRAb assay. Clinica Chimica Acta. 407(1-2). 62–66. 12 indexed citations
3.
Massart, Catherine, J Gibassier, J. de Sèze, et al.. (2008). Determination of interferon beta neutralizing antibodies in multiple sclerosis: Improvement of clinical sensitivity of a cytopathic effect assay. Clinica Chimica Acta. 391(1-2). 98–101. 2 indexed citations
4.
Massart, Catherine, Rémy Sapin, J Gibassier, Arnaud Agin, & Michèle d’Herbomez. (2008). Intermethod Variability in TSH-Receptor Antibody Measurement: Implication for the Diagnosis of Graves Disease and for the Follow-Up of Graves Ophthalmopathy. Clinical Chemistry. 55(1). 183–186. 32 indexed citations
5.
Massart, Catherine, J Gibassier, Joël Oger, Emmanuelle Le Page, & Gilles Edan. (2006). Neutralizing antibodies to interferon beta in multiple sclerosis: Analytical evaluation for validation of a cytopathic effect assay. Clinica Chimica Acta. 377(1-2). 185–191. 9 indexed citations
6.
Massart, Catherine, et al.. (2005). Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells. Anti-Cancer Drugs. 16(3). 255–261. 18 indexed citations
7.
Massart, Catherine, J Gibassier, Marie‐Christine Laurent, & D. Le Lannou. (2005). Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation. Clinical Chemistry and Laboratory Medicine (CCLM). 44(1). 105–9. 3 indexed citations
8.
Massart, Catherine, Romain Barbet, N Génetet, & J Gibassier. (2004). Doxorubicin Induces Fas-Mediated Apoptosis in Human Thyroid Carcinoma Cells. Thyroid. 14(4). 263–270. 26 indexed citations
9.
10.
Massart, Catherine, et al.. (1999). Peripheral Blood and Intrathyroidal T Cell Clones from Patients with Thyroid Autoimmune Diseases. Autoimmunity. 31(3). 163–174. 4 indexed citations
11.
Massart, Catherine, et al.. (1997). Expression of membrane and soluble intercellular adhesion molecule-1 in Graves' disease. Journal of Molecular Endocrinology. 19(2). 191–201. 5 indexed citations
12.
Massart, C., J Gibassier, Franck Le Gall, et al.. (1997). Action of peripheral or intrathyroidal lymphocytes on autologous thyrocytes cultured in follicles in collagen gel. Journal of Molecular Endocrinology. 18(2). 137–145. 4 indexed citations
13.
Massart, Catherine, E. Sonnet, J Gibassier, D Maugendre, & B Genetet. (1997). Clinical validity of intercellular adhesion molecule-1 (ICAM-1) and TSH receptor antibodies in sera from patients with Graves' disease. Clinica Chimica Acta. 265(2). 157–168. 5 indexed citations
14.
Massart, Catherine, et al.. (1996). Effect of S9788 on the efficiency of doxorubicin in vivo and in vitro in medullary thyroid carcinoma xenograft. Anti-Cancer Drugs. 7(3). 321–330. 3 indexed citations
15.
Massart, C., J Gibassier, N Génetet, et al.. (1996). Effect of lymphocytes on hormonal secretion by autologous thyrocytes cultured in monolayers. Journal of Molecular Endocrinology. 17(3). 185–195. 5 indexed citations
16.
Massart, Catherine, et al.. (1995). Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line. Anti-Cancer Drugs. 6(1). 135–146. 9 indexed citations
17.
Massart, Catherine, et al.. (1993). Modulation by dimethyl sulphoxide of the toxicity induced by cis-diamminedichloroplatinum in cultured thyrocytes. Toxicology in Vitro. 7(1). 87–94. 13 indexed citations
18.
Massart, Catherine, et al.. (1993). Hormonal study of a human mixed follicular and medullary thyroid carcinoma. Journal of Molecular Endocrinology. 11(1). 59–67. 4 indexed citations
19.
Massart, Catherine, et al.. (1992). Effects of cisplatin on human thyrocytes in monolayer or follicle culture. Journal of Molecular Endocrinology. 8(3). 243–248. 13 indexed citations
20.
Massart, Catherine, et al.. (1991). Comparison of thyroperoxidase and microsomal antibody assays in sera from patients with Graves disease. Clinical Chemistry. 37(10). 1777–1780. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mosin Saleem Khan Breakdown of academic impact, for papers by Caroline S. Kim Breakdown of academic impact, for papers by Maria Teresa Ionta Breakdown of academic impact, for papers by Bojana Janković Breakdown of academic impact, for papers by Esther Ravinsky Breakdown of academic impact, for papers by Ninni Mu Breakdown of academic impact, for papers by G Feifel Breakdown of academic impact, for papers by Constantinos Troungos Breakdown of academic impact, for papers by Daria Domańska Breakdown of academic impact, for papers by Marc‐Olivier Turgeon
Rankless by CCL
2026